Commentary / World Jun 17, 2022
by Phillip A. Sharp and Julien Patris
The rapid delivery of COVID-19 vaccines has boosted everyone’s appreciation for biotech research, but policymakers still need to heed the lessons of past success stories.
The rapid delivery of COVID-19 vaccines has boosted everyone’s appreciation for biotech research, but policymakers still need to heed the lessons of past success stories.
Omicron is turning out to be a weak vaccine
Unvaccinated people who got COVID-19 last winter have little protection from reinfection, and even vaccinated people might be vulnerable after only a few months.
Balking at boosters: Young Japanese continue to shun third shots, study finds
Kyoto University researchers have warned that the low uptake could hasten the arrival of the next COVID-19 wave.
Tourists and the Japanese art of pandemic envy
Japan is debating when and how to take off masks. The country should proceed cautiously.
Monkeypox isn’t looking like a COVID-sized threat
It’s still early, but contact-tracing efforts and analysis of the virus’s genome offer hope that this outbreak can be contained.
Japan to start fourth vaccine shots for elderly and at-risk groups Wednesday
People age 60 and older as well as younger individuals with chronic health conditions or at high risk of developing severe COVID-19 symptoms will be eligible.
What justifies China’s 'COVID Zero' policy?
In the years since COVID-19’s emergence, China has devised and implemented a highly effective disease-outbreak response system.
The Indian government and its COVID-19 con
As the recent spat with the WHO over COVID-19 mortality figures suggests, clumsy attempts to influence the global narrative will only undermine India’s international reputation.
Shanghai aims to reopen more COVID-19-shut businesses, while Beijing battles on
All but shut down for more than six weeks, Shanghai is tightening curbs in some areas that it hopes marks a final push in its campaign against the virus.
34 volunteers chose to get COVID-19. Here’s what scientists learned.
One of the first big surprises was how short the COVID incubation period was; it took only two days before the volunteers tested positive on PCR tests and soon after that on the rapid tests.
How often do we have to get COVID to stop getting COVID?
Natural immunity will be key to downshifting the pandemic to endemic status. That doesn’t mean you should go out and try to catch the virus tomorrow.
Japan's Shionogi says COVID-19 pill shows rapid clearance of virus
The pill, S-217622, "demonstrated rapid clearance of the infectious SARS-CoV-2 virus," the Japanese drugmaker Shionogi says.